AnaptysBio, Inc. (ANAB)
57.68
+0.95
(+1.67%)
USD |
NASDAQ |
Apr 02, 16:00
57.92
+0.24
(+0.42%)
After-Hours: 20:00
AnaptysBio Market Cap : 1.693B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 2.210B |
| Nektar Therapeutics | 1.355B |
| Rigel Pharmaceuticals, Inc. | 509.95M |
| Vanda Pharmaceuticals, Inc. | 409.37M |
| Adaptive Biotechnologies Corp. | 2.342B |
Market Cap Related Metrics
| PS Ratio | 7.519 |
| Price to Book Value | 45.50 |
| Price to Free Cash Flow | 89.95 |
| Price | 57.68 |
| Earnings Yield | -0.88% |
| Operating PE Ratio | 36.83 |